Cargando…

National Pharmacare in Canada: Equality or Equity, Accessibility or Affordability Comment on "Universal Pharmacare in Canada: A Prescription for Equity in Healthcare"

Canada’s federal government intends to take steps to implement national pharmacare so that all Canadians have prescription drug coverage they need at an affordable price. Relatively limited funds have so far been pledged to support national pharmacare, which raises the question: what kind of program...

Descripción completa

Detalles Bibliográficos
Autor principal: Rawson, Nigel S. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kerman University of Medical Sciences 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947647/
https://www.ncbi.nlm.nih.gov/pubmed/32610769
http://dx.doi.org/10.15171/ijhpm.2019.146
_version_ 1783663270199033856
author Rawson, Nigel S. B.
author_facet Rawson, Nigel S. B.
author_sort Rawson, Nigel S. B.
collection PubMed
description Canada’s federal government intends to take steps to implement national pharmacare so that all Canadians have prescription drug coverage they need at an affordable price. Relatively limited funds have so far been pledged to support national pharmacare, which raises the question: what kind of program is envisioned? Since the government has already introduced regulations intended to reduce new drug prices drastically, national pharmacare seems likely to be a basic system designed to assist low-income Canadians with accessing primary care medicines. What Canadians actually need is a system that provides access to the medicine considered appropriate by the patient and their healthcare provider for the patient’s specific condition. Equitable national pharmacare will not be achieved if patients are denied access to new high-cost specialized medicines that can improve or extend their lives, any more than if patients who cannot afford basic drugs are not helped.
format Online
Article
Text
id pubmed-7947647
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Kerman University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-79476472021-03-16 National Pharmacare in Canada: Equality or Equity, Accessibility or Affordability Comment on "Universal Pharmacare in Canada: A Prescription for Equity in Healthcare" Rawson, Nigel S. B. Int J Health Policy Manag Commentary Canada’s federal government intends to take steps to implement national pharmacare so that all Canadians have prescription drug coverage they need at an affordable price. Relatively limited funds have so far been pledged to support national pharmacare, which raises the question: what kind of program is envisioned? Since the government has already introduced regulations intended to reduce new drug prices drastically, national pharmacare seems likely to be a basic system designed to assist low-income Canadians with accessing primary care medicines. What Canadians actually need is a system that provides access to the medicine considered appropriate by the patient and their healthcare provider for the patient’s specific condition. Equitable national pharmacare will not be achieved if patients are denied access to new high-cost specialized medicines that can improve or extend their lives, any more than if patients who cannot afford basic drugs are not helped. Kerman University of Medical Sciences 2020-01-01 /pmc/articles/PMC7947647/ /pubmed/32610769 http://dx.doi.org/10.15171/ijhpm.2019.146 Text en © 2020 The Author(s); Published by Kerman University of Medical Sciences This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Rawson, Nigel S. B.
National Pharmacare in Canada: Equality or Equity, Accessibility or Affordability Comment on "Universal Pharmacare in Canada: A Prescription for Equity in Healthcare"
title National Pharmacare in Canada: Equality or Equity, Accessibility or Affordability Comment on "Universal Pharmacare in Canada: A Prescription for Equity in Healthcare"
title_full National Pharmacare in Canada: Equality or Equity, Accessibility or Affordability Comment on "Universal Pharmacare in Canada: A Prescription for Equity in Healthcare"
title_fullStr National Pharmacare in Canada: Equality or Equity, Accessibility or Affordability Comment on "Universal Pharmacare in Canada: A Prescription for Equity in Healthcare"
title_full_unstemmed National Pharmacare in Canada: Equality or Equity, Accessibility or Affordability Comment on "Universal Pharmacare in Canada: A Prescription for Equity in Healthcare"
title_short National Pharmacare in Canada: Equality or Equity, Accessibility or Affordability Comment on "Universal Pharmacare in Canada: A Prescription for Equity in Healthcare"
title_sort national pharmacare in canada: equality or equity, accessibility or affordability comment on "universal pharmacare in canada: a prescription for equity in healthcare"
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947647/
https://www.ncbi.nlm.nih.gov/pubmed/32610769
http://dx.doi.org/10.15171/ijhpm.2019.146
work_keys_str_mv AT rawsonnigelsb nationalpharmacareincanadaequalityorequityaccessibilityoraffordabilitycommentonuniversalpharmacareincanadaaprescriptionforequityinhealthcare